| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Published online before print October 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Klinik für Anästhesiologie und operative Intensivmedizin, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany
1 Correspondence: Klinik für Anästhesiologie und operative Intensivmedizin, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. E-mail: heike.rittner{at}charite.de
ABSTRACT
When tissue is destroyed or invaded by leukocytes in inflammation, numerous mediators are delivered by the circulation and/or liberated from resident and immigrated cells at the site. Proalgesic mediators include proinflammatory cytokines, chemokines, protons, nerve growth factor, and prostaglandins, which are produced by invading leukocytes or by resident cells. Less well known is that analgesic mediators, which counteract pain, are also produced in inflamed tissues. These include anti-inflammatory cytokines and opioid peptides. Interactions between leukocyte-derived opioid peptides and opioid receptors can lead to potent, clinically relevant inhibition of pain (analgesia). Opioid receptors are present on peripheral endings of sensory neurons. Opioid peptides are synthesized in circulating leukocytes, which migrate to inflamed tissues directed by chemokines and adhesion molecules. Under stressful conditions or in response to releasing agents (e.g., corticotropin-releasing factor, cytokines, noradrenaline), leukocytes can secrete opioids. They activate peripheral opioid receptors and produce analgesia by inhibiting the excitability of sensory nerves and/or the release of excitatory neuropeptides. This review presents discoveries that led to the concepts of pain generation by mediators secreted from leukocytes and of analgesia by immune-derived opioids.
Key Words: inflammation • neuropathy • hyperalgesia • cytokines • chemokines • opioid peptides
This article has been cited by other articles:
|
|
 |
|
  S. Hagiwara, H. Iwasaka, A. Hasegawa, and T. Noguchi Pre-Irradiation of Blood by Gallium Aluminum Arsenide (830 nm) Low-Level Laser Enhances Peripheral Endogenous Opioid Analgesia in Rats Anesth. Analg., September 1, 2008; 107(3): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Lian, J. Dahl, P. W. Ackermann, F. Frihagen, L. Engebretsen, and R. Bahr Pronociceptive and Antinociceptive Neuromediators in Patellar Tendinopathy Am. J. Sports Med., November 1, 2006; 34(11): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Eicher, H. W. Cheng, A. D. Sorrells, and M. M. Schutz Short communication: behavioral and physiological indicators of sensitivity or chronic pain following tail docking. J Dairy Sci, August 1, 2006; 89(8): 3047 - 3051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shen, H. Sprott, A. Aeschlimann, R. E. Gay, B. A. Michel, S. Gay, and H. Sprott Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee Rheumatology, June 1, 2006; 45(6): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Rittner, S. A. Mousa, D. Labuz, K. Beschmann, M. Schafer, C. Stein, and A. Brack Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain J. Leukoc. Biol., May 1, 2006; 79(5): 1022 - 1032. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
